Mikito Ito
University of Tokyo
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Mikito Ito.
Oncogene | 2000
Shinichi Kanno; Nobuyuki Oda; Mayumi Abe; Yoshito Terai; Mikito Ito; Kenya Shitara; Koichi Tabayashi; Masabumi Shibuya; Yasufumi Sato
Vascular endothelial growth factor (VEGF) is a principal regulator of vasculogenesis and angiogenesis. VEGF expresses its effects by binding to two VEGF receptors, Flt-1 and KDR. However, properties of Flt-1 and KDR in the signal transduction of VEGF-mediated effects in endothelial cells (ECs) were not entirely clarified. We investigated this issue by using two newly developed blocking monoclonal antibodies (mAbs) against Flt-1 and KDR. VEGF elicits DNA synthesis and cell migration of human umbilical vein endothelial cells (HUVECs). The pattern of inhibition of these effects by two mAbs indicates that DNA synthesis is preferentially mediated by KDR. In contrast, the regulation of cell migration by VEGF appears to be more complicated. Flt-1 regulates cell migration through modulating actin reorganization, which is essential for cell motility. A distinct signal is generated by KDR, which influences cell migration by regulating cell adhesion via the assembly of vinculin in focal adhesion plaque and tyrosine-phosphorylation of focal adhesion kinase (FAK) and paxillin.
Journal of Biological Chemistry | 1998
Akeo Shinkai; Mikito Ito; Hideharu Anazawa; Sachiko Yamaguchi; Kenya Shitara; Masabumi Shibuya
The kinase insert domain-containing receptor (KDR) for vascular endothelial growth factor (VEGF) has been shown to be involved in vasculogenesis and angiogenesis. This receptor is characterized by seven immunoglobulin (Ig)-like domains within its extracellular region. To identify the domains involved in VEGF binding, we constructed various deletion mutants of the extracellular region fused with the crystallizable fragment portion of an IgG and then examined the binding affinity with VEGF by means of the BIAcore biosensor assay. Deletion of the COOH-terminal two or three Ig-like domains out of a total of seven affected ligand dissociation rather than association. Further deletion of the fourth domain caused a drastic decrease in the association rate. Binding ability was abolished completely with removal of the third domain. The mutant KDR proteins lacking the NH2-terminal Ig-like domain exhibited a slightly higher association rate compared with those of the mutants having this domain. Deletion of the first two NH2-terminal Ig-like domains caused a drastic reduction in the association rate, but affinity to VEGF was retained. These results suggest that the third Ig-like domain is critical for ligand binding, the second and fourth domains are important for ligand association, and the fifth and sixth domains are required for retention of the ligand bound to the receptor molecule. The first Ig-like domain may regulate the ligand binding.
Annals of the New York Academy of Sciences | 2006
Yasufumi Sato; Shinichi Kanno; Nobuyuki Oda; Mayumi Abe; Mikito Ito; Kenya Shitara; Masabumi Shibuya
Abstract: The properties of two VEGF receptors, Flt‐1 and KDR, in the signal transduction of VEGF in human umbilical vein endothelial cells (HUVECs) were investigated by using two newly developed blocking monoclonal antibodies (mAbs) against Flt‐1 and KDR. VEGF stimulated the expression of transcription factor Ets‐1 as well as matrix metalloproteinase‐1 (MMP‐1) and Flt‐1 in HUVECs. The KDR/Flt‐1 heterodimer and the KDR homodimer mediate the expression of Ets‐1, MMP‐1, and Flt‐1. VEGF also stimulated DNA synthesis and migration of HUVECs. DNA synthesis is mediated by the same signaling system as the expression of Ets‐1. In contrast, cell migration is regulated by two distinct signaling systems. The Flt‐1 homodimer is required for actin reorganization. The KDR/Flt‐1 heterodimer and the KDR homodimer are required for the assembly of vinculin in focal adhesion plaque by regulating the phosphorylation of focal adhesion kinase (FAK) and paxillin.
Blood | 2001
Asako Sawano; Shinobu Iwai; Yoshiko Sakurai; Mikito Ito; Kenya Shitara; Tatsutoshi Nakahata; Masabumi Shibuya
Archive | 2006
Kenya Shitara; Mikito Ito; Nobuo Hanai; Yoko Kawada; Kazuyasu Nakamura; Masabumi Shibuya
Archive | 1999
Kenya Shitara; Mikito Ito; Nobuo Hanai; Akeo Shinkai; Hideharu Anazawa; Masabumi Shibuya
Archive | 1999
Kenya Shitara; Mikito Ito; Nobuo Hanai; Junji Kanazawa; Tatsuya Tamaoki; Masabumi Shibuya
Archive | 1999
Kenya Shitara; Mikito Ito; Yoko Kawada; Kazuyasu Nakamura
Archive | 1999
Kenya Shitara; Mikito Ito; Yoko Kawada; Kazuyasu Nakamura
Archive | 1999
Kenya Shitara; Mikito Ito; Nobuo Hanai; Junji Kanazawa; Tatsuya Tamaoki; Masabumi Shibuya